From StopAfib.org - For Afib Patients, By Afib Patients
Team AFib presented a webinar, AFib CARE: Creating a Role for Effective Teams, in honor of National Atrial Fibrillation Awareness Month in 2011. A panel of healthcare providers and caregivers provided important information to help patients and caregivers work with members of their healthcare teams. If you didn’t get a chance to tune in to [...]
The wildly beating heart, fatigue and other debilitating symptoms are well known to the many millions of people impacted by atrial fibrillation. Some of those who have afib may have no outward symptoms, but are still at risk of serious and long-term damage to the heart.
Symptoms or not, rate control is the common treatment of choice, especially from those healthcare providers who are not well versed in afib treatment options. But this treatment sort of suspends afib patients in a “waiting and watching” middle ground, stuck in limbo with a diminished quality of life and an increased risk of stroke.
Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate [...]
A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial [...]
The US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to [...]
The US Food & Drug Administration (FDA) Advisory Committee just voted 9-2, with 1 abstaining, to recommend that the FDA approve rivaroxaban (Xarelto) for prevention of atrial fibrillation strokes. See our full story, now up at: FDA Panel Votes for Rivaroxaban: Atrial Fibrillation Patients May Soon Have Two Alternatives to Warfarin for Stroke Prevention
In honor of Atrial Fibrillation (Afib) Awareness Month, Team AFib would like to invite you to our second webinar, “AFib CARE: Creating A Role for Effective Teams”, taking place at 1:00 p.m. ET on Wednesday, September 14 and hosted by StopAfib.org. To learn more, see: Join Team AFib’s Atrial Fibrillation Webinar, “AFib CARE: Creating A [...]
Team AFib is a newly-formed coalition of organizations that advocates for atrial fibrillation patients. Join Team AFib on a national tour to raise awareness about afib and its link to an increased risk for stroke. To learn more, see: Announcing Team AFib, a new coalition to advocate for atrial fibrillation patients, which includes StopAfib.org
A study presented at the recent American College of Cardiology Scientific Sessions by Dr. Matthew Reynolds of the Harvard Clinical Research Institute showed that having a radiofrequency (RF) catheter ablation for atrial fibrillation could reduce the risk of stroke by 40% compared to those who did not have an ablation. To learn more, see: Radiofrequency [...]
StopAfib.org founder Mellanie True Hills with daytime TV star Susan Lucci and her husband Helmut Huber announcing Facing AFib partnership StopAfib.org is proud to participate in the Facing AFib program, which features daytime TV star Susan Lucci and her husband Helmut Huber. More than a decade ago, Huber was diagnosed with afib. Lucci and Huber [...]
